SOLV (STOCKS)
Solventum Corporation
$76.900000
-1.970000 (-2.50%)
Prev close: $78.870000
Company Information
- Exchange
- XNYS
- Sector
- Health Services
- Industry
- Medical/Nursing Services
- CEO
- Bryan C. Hanson
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $13,318.87M
- Employees
- 22,000
- P/E (TTM)
- 9.42
- P/B (TTM)
- 2.69
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
6
Strong Buy
6
Buy
8
Hold
2
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$1.48 | $1.38 | +0.1012 | +7.34% |
|
Dec 2025 (Q4)
|
$1.57 | $1.53 | +0.0445 | +2.92% |
|
Sep 2025 (Q3)
|
$1.50 | $1.46 | +0.0388 | +2.66% |
|
Jun 2025 (Q2)
|
$1.69 | $1.47 | +0.2215 | +15.08% |
Financial Statements
| Revenues | $8.26B |
| Benefits Costs and Expenses | $6.57B |
| Cost Of Revenue | $3.83B |
| Costs And Expenses | $6.57B |
| Gross Profit | $4.43B |
| Operating Expenses | $2.33B |
| Selling, General, and Administrative Expenses | $3.14B |
| Research and Development | $736.00M |
| Operating Income/Loss | $2.11B |
| Income/Loss From Continuing Operations After Tax | $1.43B |
| Income/Loss From Continuing Operations Before Tax | $1.69B |
| Income Tax Expense/Benefit | $259.00M |
| Income Tax Expense/Benefit, Deferred | -$17.00M |
| Net Income/Loss | $1.43B |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $1.43B |
| Net Income/Loss Available To Common Stockholders, Basic | $1.43B |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $8.21 |
| Diluted Earnings Per Share | $8.15 |
| Basic Average Shares | 522,700,000 |
| Diluted Average Shares | 526,300,000 |
| Assets | $14.10B |
| Current Assets | $3.58B |
| Inventory | $1.09B |
| Other Current Assets | $2.49B |
| Noncurrent Assets | $10.51B |
| Intangible Assets | $2.50B |
| Other Non-current Assets | $8.02B |
| Liabilities | $9.13B |
| Current Liabilities | $3.35B |
| Accounts Payable | $699.00M |
| Wages | $167.00M |
| Other Current Liabilities | $2.48B |
| Noncurrent Liabilities | $5.78B |
| Equity | $4.97B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $4.97B |
| Liabilities And Equity | $14.10B |
| Net Cash Flow From Operating Activities | $151.00M |
| Net Cash Flow From Operating Activities, Continuing | $151.00M |
| Net Cash Flow From Investing Activities | $2.83B |
| Net Cash Flow From Investing Activities, Continuing | $2.83B |
| Net Cash Flow From Financing Activities | -$2.97B |
| Net Cash Flow From Financing Activities, Continuing | -$2.97B |
| Net Cash Flow | $17.00M |
| Net Cash Flow, Continuing | $17.00M |
| Comprehensive Income/Loss | $1.66B |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $1.66B |
| Other Comprehensive Income/Loss | $1.66B |
| Other Comprehensive Income/Loss Attributable To Parent | $228.00M |